MIFH
DTIL icon

Migdal Insurance & Financial Holdings’s Precision BioSciences DTIL Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,210
Closed -$686K – 610
2021
Q1 		$686K Buy
2,210
+1,372
+164% +$480K 0.01% 286
2020
Q4 		$210K Buy
+838
New +$205K ﹤0.01% 311

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Migdal Insurance & Financial Holdings's DTIL Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Precision BioSciences (DTIL) in Q2 2021, closing a stake of 2,210 shares — an estimated $686K sold.

Migdal Insurance & Financial Holdings first reported a position in DTIL in Q4 2020 and held it in 2 quarters. The position peaked at $686K in Q1 2021. 130 funds tracked by Wall St. Rank hold DTIL as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Precision BioSciences position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 2,210 Precision BioSciences shares in Q2 2021, an estimated $686K.
  • Migdal Insurance & Financial Holdings first reported a position in Precision BioSciences in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Precision BioSciences position peaked at $686K in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.